Survival analysis of patients with advanced non‐small cell lung cancer receiving tyrosine kinase inhibitor (TKI) treatment: A multi‐center retrospective study

BACKGROUND: The study was conducted to assess differences in overall survival (OS) in patients with non‐small cell lung cancer (NSCLC) receiving different treatment modalities of tyrosine kinase inhibitors (TKIs). METHODS: A total of 463 NSCLC patients receiving TKI treatment were included. OS was c...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Qingming, Guan, Maojing, Wang, Yong, Xu, Congjing, Tang, Lei, Fu, Wenhua, Bi, Minghong, Sun, Xiang, Gu, Kangsheng, Pang, Dongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792746/
https://www.ncbi.nlm.nih.gov/pubmed/29266865
http://dx.doi.org/10.1111/1759-7714.12577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792746/
https://www.ncbi.nlm.nih.gov/pubmed/29266865
http://dx.doi.org/10.1111/1759-7714.12577

Ejemplares similares